120 related articles for article (PubMed ID: 8266034)
1. [Association between lipoprotein(a) and coronary disease].
Bovet P; Burnand B; Kappenberger L; Riesen W; Darioli R
Schweiz Med Wochenschr; 1993 Nov; 123(45):2138-46. PubMed ID: 8266034
[TBL] [Abstract][Full Text] [Related]
2. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
[TBL] [Abstract][Full Text] [Related]
3. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
4. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
Ezhov MV; Afanas'ev OI; Benevolenskaia GF; Savchenko AP; Liakishev AA; Pokrovskiĭ SN
Ter Arkh; 1997; 69(9):31-4. PubMed ID: 9411822
[TBL] [Abstract][Full Text] [Related]
5. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
6. Association between incidence of lipoprotein(a) positivity and coronary heart disease.
Vashisht S; Wasir H; Srivastava LM
Indian Heart J; 1992; 44(4):223-6. PubMed ID: 1289218
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Lipoprotein(a) levels between elderly and middle-aged men with coronary artery disease.
Cicek H; Bayil S; Zer Y; Celik A; Geyikli I
Ann N Y Acad Sci; 2007 Apr; 1100():179-84. PubMed ID: 17460176
[TBL] [Abstract][Full Text] [Related]
8. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
9. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
[TBL] [Abstract][Full Text] [Related]
11. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
Agoşton-Coldea L; Rusu LD; Zdrenghea D; Rusu ML; Pop D; Crăciun A; Poanta L; Gatfossé M; Rosenstingl S; Mocan T
Rom J Intern Med; 2008; 46(2):137-44. PubMed ID: 19284085
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific associations of lipoprotein(a) with presence and quantity of coronary artery calcification in an asymptomatic population.
Cassidy AE; Bielak LF; Kullo IJ; Klee GG; Turner ST; Sheedy PF; Peyser PA
Med Sci Monit; 2004 Sep; 10(9):CR493-503. PubMed ID: 15328481
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiological study of hyperlipemia in a Lebanese population].
Aydenian H; Fadel MA; Baddoura R
Ann Biol Clin (Paris); 1999; 57(6):697-703. PubMed ID: 10572218
[TBL] [Abstract][Full Text] [Related]
15. [Detection of serum Lp(a) level of coronary heart disease and its clinical significance].
Liang XH; Huang CZ
Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):227-8. PubMed ID: 12536688
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome.
Onat A; Hergenç G; Ozhan H; Kaya Z; Bulur S; Ayhan E; Can G
Coron Artery Dis; 2008 May; 19(3):125-31. PubMed ID: 18418227
[TBL] [Abstract][Full Text] [Related]
17. Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjects.
Lecerf JM; Masson A; Fruchart JC; Bard JM
Diabetes Metab; 1996 Oct; 22(5):331-40. PubMed ID: 8896995
[TBL] [Abstract][Full Text] [Related]
18. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol and lipoprotein(a) as risk factors for coronary heart disease in elderly subjects.
Stober C; Clarke A; Mulvaney A; Harland J; Neithercut WD
Br J Biomed Sci; 1994 Jun; 51(2):114-8. PubMed ID: 8049607
[TBL] [Abstract][Full Text] [Related]
20. Lipoproteina(a) is a feature of the presence, diffuseness, and severity of coronary artery disease in Saudi population.
Habib SS; Abdel-Gader AM; Kurdi MI; Al-Aseri Z; Soliman MM
Saudi Med J; 2009 Mar; 30(3):346-52. PubMed ID: 19271061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
